
Latin America Protein Expression Market Report and Forecast 2024-2032
Description
Latin America Protein Expression Market Report and Forecast 2024-2032
Latin America Protein Expression Market Report and Forecast 2024-2032
Latin America Protein Expression Market Size
The global protein expression market was valued at USD 3 billion in 2023, with Latin America holding a significant market share. It is expected to grow at a CAGR of 9.8% during the forecast period of 2024-2032. The market is poised to secure a market value of USD 4.9 billion by 2032, driven by the increased protein-based research and development activities across the region.
Latin America Protein Expression Market Outlook
- The market is anticipated to be driven by increasing technological advancements in biotechnology and product developments by researchers.
- In June 2023, researchers from the National University of Quilmes in Argentina and the Technical University of Dresden in Germany collaborated and achieved significant breakthroughs in understanding the development of insulin in the body, focusing specifically on proteins found in the pancreas. Such research driven initiatives are likely to boost the Latin America protein expression market value in the forecast period.
- In October 2023, São Paulo State University (UNESP) researchers developed an anti-inflammatory hydrogel based on a protein used in regulating inflammation. Such research initiatives are expected to boost the market growth.
Protein expression is extensively used in healthcare research and development activities intended to develop modern therapeutics to combat chronic diseases such as cancer and diabetes among others. To meet the rising demand, the market is driven by high-profile collaborations contributing to the development of advanced technologies and potentially attracting investors for further partnerships. For instance, in June 2023, researchers from the National University of Quilmes in Argentina and the Technical University of Dresden in Germany collaborated and achieved significant breakthroughs in understanding how insulin is made in the body. This collaboration underscored the enhancement of Latin American expertise in biotechnology, positioning it as an emerging force in global medical research. Such research initiatives, aimed at developing a better understanding of proteins is projected to boost the Latin America protein expression market growth in the forecast period.
The protein expression market value is also impacted by increasing incidence of chronic diseases such as diabetes. In Brazil, nearly 10.25% of adults claimed to have been diagnosed with diabetes in 2023. It is estimated that diabetes will affect 11.6 million Brazilians by 2025 and Brazil is expected to become one of the top 10 diabetic countries in the world. Consequently, the market is witnessing increased development of effective therapeutics by researchers for diabetic patients. For instance, in October 2023, researchers at São Paulo State University (UNESP) developed an anti-inflammatory hydrogel based on annexin A1 (AnxA1), a protein involved in regulating inflammation in diabetic patients. The Latin America protein expression market demand is projected to be fuelled by the advent of such alternatives, which has the potential to become a groundbreaking treatment for nearly 17.7 million diabetic Brazilians. Successful application of this hydrogel in treating diabetic wounds may potentially contribute to the development of similar therapeutic products in the market. This can also be used in the development of more specialized and targeted therapies.
One of the significant Latin America protein expression market trends also include enhanced capabilities of the region in protein research and production, which can contribute to the establishment of new biotech companies and the expansion of existing ones. Thereby, increasing the availability of cutting-edge treatments in the market.
Latin America Protein Expression Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Expression Vectors
Competent Cells
Reagents
Instruments
Services
Market Breakup by Application
Industrial
Research
Therapeutic
Market Breakup by System Type
Mammalian Cell Expression System
Yeast Cell Expression System
Insect Cell Expression System
Market Breakup by End User
Academic Research
Contract Research Organizations
Pharmaceutical and Biotechnology Companies
Market Breakup by Country
Brazil
Argentina
Mexico
Others
Market Breakup Categories
Product Expression Vectors, Competent Cells, Reagents, Instruments, Services
Application Industrial, Research, Therapeutic
System Type Mammalian Cell Expression System, Yeast Cell Expression System, Insect Cell Expression System
End User Academic Research, Contract Research Organizations, Pharmaceutical & Biotechnology Companies
Country Brazil, Argentina, Mexico, Others
Leading Players in the Latin America Protein Expression Market
The key features of the market report include grants analysis, patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Lonza Group AG
- Agilent Technologies, Inc.
- New England Biolabs.
- Takara Bio Inc
- Danaher Corporation
- Promega Corporation
- QIAGEN
- Bio-Rad Laboratories, Inc.
- GenScript Biotech Corporation
FAQs
- What was the Latin America protein expression market forecast outlook for 2024-2032?
- What are the major factors aiding the Latin America protein expression market demand?
- What are the major Latin America protein expression market trends?
- What are the various products in the market?
- Where does protein expression find its applications?
- What is the market segmentation based on system type?
- Who are the end users in the market?
- What is the market segmentation by country?
- Who are the key players in the Latin America protein expression market?
Meta description
The Latin America protein expression market size is poised for growth, driven by the expansion of the global market, was valued at USD 3 billion in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period of 2024-2032.
*Please Note:* The report will take 7 business days to complete, after order confirmation.
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Latin America Protein Expression Market Overview
- 3.1 Latin America Protein Expression Market Historical Value (2017-2023)
- 3.2 Latin America Protein Expression Market Forecast Value (2024-2032)
- 4 Latin America Protein Expression Market Landscape*
- 4.1 Latin America Neonatal Ventilators: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Latin America Neonatal Ventilators: Product Landscape
- 4.2.1 Analysis by Product
- 4.2.2 Analysis by Application
- 5 Latin America Protein Expression Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Latin America Protein Expression Market Segmentation (2017-2032)
- 6.1 Latin America Protein Expression Market (2017-2032) by Product
- 6.1.1 Market Overview
- 6.1.2 Expression Vectors
- 6.1.3 Competent Cells
- 6.1.4 Reagents
- 6.1.5 Instruments
- 6.1.6 Services
- 6.2 Latin America Protein Expression Market (2017-2032) by Application
- 6.2.1 Market Overview
- 6.2.2 Industrial
- 6.2.3 Research
- 6.2.4 Therapeutic
- 6.3 Latin America Protein Expression Market (2017-2032) by System Type
- 6.3.1 Market Overview
- 6.3.2 Mammalian Cell Expression System
- 6.3.3 Yeast Cell Expression System
- 6.3.4 Insect Cell Expression System
- 6.4 Latin America Protein Expression Market (2017-2032) by End User
- 6.4.1 Market Overview
- 6.4.2 Academic Research
- 6.4.3 Contract Research Organizations
- 6.4.4 Pharmaceutical & Biotechnology Companies
- 6.5 Latin America Protein Expression Market (2017-2032) by Country
- 6.5.1 Market Overview
- 6.5.2 Brazil
- 6.5.3 Argentina
- 6.5.4 Mexico
- 6.5.5 Others
- 7 Brazil Protein Expression Market (2017-2032)
- 7.1 Brazil Protein Expression Market (2017-2032) by Product
- 7.1.1 Market Overview
- 7.1.2 Expression Vectors
- 7.1.3 Competent Cells
- 7.1.4 Reagents
- 7.1.5 Instruments
- 7.1.6 Services
- 7.2 Brazil Protein Expression Market (2017-2032) by Application
- 7.2.1 Market Overview
- 7.2.2 Industrial
- 7.2.3 Research
- 7.2.4 Therapeutic
- 7.3 Brazil Protein Expression Market (2017-2032) by System Type
- 7.3.1 Market Overview
- 7.3.2 Mammalian Cell Expression System
- 7.3.3 Yeast Cell Expression System
- 7.3.4 Insect Cell Expression System
- 7.4 Brazil Protein Expression Market (2017-2032) by End User
- 7.4.1 Market Overview
- 7.4.2 Academic Research
- 7.4.3 Contract Research Organizations
- 7.4.4 Pharmaceutical & Biotechnology Companies
- 8 Argentina Protein Expression Market (2017-2032)
- 8.1 Argentina Protein Expression Market (2017-2032) by Product
- 8.1.1 Market Overview
- 8.1.2 Expression Vectors
- 8.1.3 Competent Cells
- 8.1.4 Reagents
- 8.1.5 Instruments
- 8.1.6 Services
- 8.2 Argentina Protein Expression Market (2017-2032) by Application
- 8.2.1 Market Overview
- 8.2.2 Industrial
- 8.2.3 Research
- 8.2.4 Therapeutic
- 8.3 Argentina Protein Expression Market (2017-2032) by System Type
- 8.3.1 Market Overview
- 8.3.2 Mammalian Cell Expression System
- 8.3.3 Yeast Cell Expression System
- 8.3.4 Insect Cell Expression System
- 8.4 Argentina Protein Expression Market (2017-2032) by End User
- 8.4.1 Market Overview
- 8.4.2 Academic Research
- 8.4.3 Contract Research Organizations
- 8.4.4 Pharmaceutical & Biotechnology Companies
- 9 Mexico Protein Expression Market (2017-2032)
- 9.1 Mexico Protein Expression Market (2017-2032) by Product
- 9.1.1 Market Overview
- 9.1.2 Expression Vectors
- 9.1.3 Competent Cells
- 9.1.4 Reagents
- 9.1.5 Instruments
- 9.1.6 Services
- 9.2 Mexico Protein Expression Market (2017-2032) by Application
- 9.2.1 Market Overview
- 9.2.2 Industrial
- 9.2.3 Research
- 9.2.4 Therapeutic
- 9.3 Mexico Protein Expression Market (2017-2032) by System Type
- 9.3.1 Market Overview
- 9.3.2 Mammalian Cell Expression System
- 9.3.3 Yeast Cell Expression System
- 9.3.4 Insect Cell Expression System
- 9.4 Mexico Protein Expression Market (2017-2032) by End User
- 9.4.1 Market Overview
- 9.4.2 Academic Research
- 9.4.3 Contract Research Organizations
- 9.4.4 Pharmaceutical & Biotechnology Companies
- 10 Regulatory Framework
- 11 Grants Analysis
- 11.1 Analysis by Year
- 11.2 Analysis by Amount Awarded
- 11.3 Analysis by Issuing Authority
- 11.4 Analysis by Grant Application
- 11.5 Analysis by Funding Institute
- 11.6 Analysis by Departments
- 11.7 Analysis by Recipient Organization
- 12 Funding and Investment Analysis
- 12.1 Analysis by Funding Instances
- 12.2 Analysis by Product of Funding
- 12.3 Analysis by Funding Amount
- 12.4 Analysis by Leading Players
- 12.5 Analysis by Leading Investors
- 12.6 Analysis by Geography
- 13 Partnership and Collaborations Analysis
- 13.1 Analysis by Partnership Instances
- 13.2 Analysis by Type of Partnership
- 13.3 Analysis by Leading Players
- 13.4 Analysis by Geography
- 14 Supplier Landscape
- 14.1 Market Share by Top 5 Companies
- 14.2 Merck KGaA
- 14.2.1 Financial Analysis
- 14.2.2 Product Portfolio
- 14.2.3 Demographic Reach and Achievements
- 14.2.4 Mergers and Acquisitions
- 14.2.5 Certifications
- 14.3 Thermo Fisher Scientific Inc.
- 14.3.1 Financial Analysis
- 14.3.2 Product Portfolio
- 14.3.3 Demographic Reach and Achievements
- 14.3.4 Mergers and Acquisitions
- 14.3.5 Certifications
- 14.4 Lonza Group AG
- 14.4.1 Financial Analysis
- 14.4.2 Product Portfolio
- 14.4.3 Demographic Reach and Achievements
- 14.4.4 Mergers and Acquisitions
- 14.4.5 Certifications
- 14.5 Agilent Technologies, Inc.
- 14.5.1 Financial Analysis
- 14.5.2 Product Portfolio
- 14.5.3 Demographic Reach and Achievements
- 14.5.4 Mergers and Acquisitions
- 14.5.5 Certifications
- 14.6 New England Biolabs.
- 14.6.1 Financial Analysis
- 14.6.2 Product Portfolio
- 14.6.3 Demographic Reach and Achievements
- 14.6.4 Mergers and Acquisitions
- 14.6.5 Certifications
- 14.7 Takara Bio Inc.
- 14.7.1 Financial Analysis
- 14.7.2 Product Portfolio
- 14.7.3 Demographic Reach and Achievements
- 14.7.4 Mergers and Acquisitions
- 14.7.5 Certifications
- 14.8 Danaher Corporation
- 14.8.1 Financial Analysis
- 14.8.2 Product Portfolio
- 14.8.3 Demographic Reach and Achievements
- 14.8.4 Mergers and Acquisitions
- 14.8.5 Certifications
- 14.9 Promega Corporation
- 14.9.1 Financial Analysis
- 14.9.2 Product Portfolio
- 14.9.3 Demographic Reach and Achievements
- 14.9.4 Mergers and Acquisitions
- 14.9.5 Certifications
- 14.10 QIAGEN
- 14.10.1 Financial Analysis
- 14.10.2 Product Portfolio
- 14.10.3 Demographic
- 14.10.4 Mergers and Acquisitions
- 14.10.5 Certifications
- 14.11 Bio-Rad Laboratories, Inc.
- 14.11.1 Financial Analysis
- 14.11.2 Product Portfolio
- 14.11.3 Demographic Reach and Achievements
- 14.11.4 Mergers and Acquisitions
- 14.11.5 Certifications
- 14.12 GenScript Biotech Corporation
- 14.12.1 Financial Analysis
- 14.12.2 Product Portfolio
- 14.12.3 Demographic Reach and Achievements
- 14.12.4 Mergers and Acquisitions
- 14.12.5 Certifications
- 15 Latin America Protein Expression Market – Distribution Model (Additional Insight)
- 15.1 Overview
- 15.2 Potential Distributors
- 15.3 Key Parameters for Distribution Partner Assessment
- 16 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 17 Company Competitiveness Analysis (Additional Insight)
- 17.1 Very Small Companies
- 17.2 Small Companies
- 17.3 Mid-Sized Companies
- 17.4 Large Companies
- 17.5 Very Large Companies
- 18 Payment Methods (Additional Insight)
- 18.1 Government Funded
- 18.2 Private Insurance
- 18.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.